These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 24163369)
1. Local depletion of DNA methylation identifies a repressive p53 regulatory region in the NEK2 promoter. Nabilsi NH; Ryder DJ; Peraza-Penton AC; Poudyal R; Loose DS; Kladde MP J Biol Chem; 2013 Dec; 288(50):35940-51. PubMed ID: 24163369 [TBL] [Abstract][Full Text] [Related]
2. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Majid S; Dar AA; Ahmad AE; Hirata H; Kawakami K; Shahryari V; Saini S; Tanaka Y; Dahiya AV; Khatri G; Dahiya R Carcinogenesis; 2009 Apr; 30(4):662-70. PubMed ID: 19221000 [TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538 [TBL] [Abstract][Full Text] [Related]
4. Gene reactivation by 5-aza-2'-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. Yang X; Noushmehr H; Han H; Andreu-Vieyra C; Liang G; Jones PA PLoS Genet; 2012; 8(3):e1002604. PubMed ID: 22479200 [TBL] [Abstract][Full Text] [Related]
5. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. Mossman D; Kim KT; Scott RJ BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997 [TBL] [Abstract][Full Text] [Related]
6. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Magdinier F; Wolffe AP Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512 [TBL] [Abstract][Full Text] [Related]
7. Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway. Widodo N; Deocaris CC; Kaur K; Hasan K; Yaguchi T; Yamasaki K; Sugihara T; Ishii T; Wadhwa R; Kaul SC J Gerontol A Biol Sci Med Sci; 2007 Mar; 62(3):246-55. PubMed ID: 17389721 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells. Wang G; Wei LN; Loh HH J Biol Chem; 2003 Oct; 278(42):40550-6. PubMed ID: 12890683 [TBL] [Abstract][Full Text] [Related]
9. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine. Karpf AR; Moore BC; Ririe TO; Jones DA Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619 [TBL] [Abstract][Full Text] [Related]
10. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219 [TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327 [TBL] [Abstract][Full Text] [Related]
12. Interactions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation. Su D; Wang X; Campbell MR; Song L; Safi A; Crawford GE; Bell DA PLoS Genet; 2015 Jan; 11(1):e1004885. PubMed ID: 25569532 [TBL] [Abstract][Full Text] [Related]
13. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor. Deng G; Song GA; Pong E; Sleisenger M; Kim YS Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381 [TBL] [Abstract][Full Text] [Related]
14. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex. Fischer M; Quaas M; Nickel A; Engeland K Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675 [TBL] [Abstract][Full Text] [Related]
15. Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation. Cho Y; Turner ND; Davidson LA; Chapkin RS; Carroll RJ; Lupton JR Exp Biol Med (Maywood); 2014 Mar; 239(3):302-10. PubMed ID: 24495951 [TBL] [Abstract][Full Text] [Related]
16. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer. Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473 [TBL] [Abstract][Full Text] [Related]